Pfizer

Pfizer Will Reward Shareholders With Zoetis Spin-Off

Pfizer Terminates Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility

Drug Giants Such as Bayer AG, Pfizer Inc., and Roche Accused of Shady Soviet-Era Drug Trials

Johnson & Johnson: We're Creaming Medivation, Inc., Boehringer Ingelheim Corporation, Bristol-Myers Squibb Company and Pfizer Inc.

2 Stocks to Buy, 2 to Sell in Big Pharma

Pfizer Has Potential To Grow Despite Decreasing Sales

[Correspondence] Tofacitinib for rheumatoid arthritis – Authors'reply

Pfizer: split-off

Another Look At Marketing Vs. R&D In Pharma

Wall Street Fundamentals Releases New In-Depth Stock Reports on BAC, GE, PFE and VZ (NYS,NYS,NYS,NYS:BAC,GE,PFE,VZ)